Cancer cells can use lipids not just as fuel, but as a means to obscure inflammatory signals, enabling immune evasion.

There is no general implemented and fully protective preventative treatment available for Group B Streptococcus.

An international collaboration of researchers in Europe and the U.S. has identified a critical immune factor for host defense against Staphylococcus aureus, which could offer a potential explanation ...

DFI therapy cost the UK’s NHS up to £962 million ($1.27 billion) each year. In the U.S., amputation cost alone is $1.38 ...

Using engineered mice, researchers developed monoclonal antibodies that were effective against infection with A. baumannii.

A Wyss Institute team has been selected to develop a broad-spectrum antimicrobial therapeutic under a contract from the DARPA ...

At Princeton University, scientists have been nudging DNA by using light-inducible biomolecular condensates to generate capillary forces at targeted DNA loci. These condensates are part of a platform ...

Researcher suggest CREME provides a powerful toolkit for translating the predictions of genomic deep neural networks into mechanistic insights of gene regulation ...

T cells refueled with extra mitochondria exhibited heightened antitumor activity and reduced signs of exhaustion in ...

The interest rate cut expected this week has a potential double impact of opening financial options to emerging growth ...

Reactivation of Epstein–Barr virus infection increases the production of neoself-antigens, which induce an autoimmune response, in patients with lupus.

Moderna jolted investors by pushing back its profitability forecast two years, to 2028, and announcing a $1.1 billion cut in R&D spending.